Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

Clinical trial NCT02132000 · UNKNOWN

Trial details

NCT number: NCT02132000
Sponsor: Fengxi Su
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Breast Cancer Patients in Premenopausal Estrogen and/or Progesterone Receptor Positive

Start date: 2014-04-01
Primary completion: 2020-05-01
Enrollment: 3036

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.